Literature DB >> 19955808

Complementary and alternative medicine in lung cancer patients: a neglected phenomenon?

O Micke, J Büntzel, K Kisters, U Schäfer, P Micke, R Mücke.   

Abstract

Study on the use of complementary and alternative medicine (CAM) in lung cancer patients has been widely neglected. Therefore, we initiated a study on the use of CAM in lung cancer patients in addition to radiation treatment. Overall, 120 patients from 3 institutions were interviewed by a standardized questionnaire. Besides the tumor parameters and the use of CAM, the reason for the use, patient information of the medication, the information sources and the subjective condition of the patient. Altogether, 54% of the patients reported using CAM (66% of female patients, 52% of male patients). The most frequently used CAM measures were vitamin combinations (17%), mistletoe (15%), and selenium (12%). A total of 52% reported the wish to support the tumor treatment as a reason for using CAM and 27% had a 'better feeling' using CAM. 50% of CAM was bought by the patients themselves and 50% were prescribed by their family physicians. The use of CAM is frequent in lung cancer patients. Our results suggest that it is very important to obtain information on the CAM use of patients and, particularly in controlled clinical trials, to prospectively document it. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19955808     DOI: 10.1159/000262477

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN: 0071-9676


  12 in total

Review 1.  Great expectations: what do patients using complementary and alternative medicine hope for?

Authors:  E Ernst; S K Hung
Journal:  Patient       Date:  2011       Impact factor: 3.883

2.  Protective effects of sodium selenite supplementation against irradiation-induced damage in non-cancerous human esophageal cells.

Authors:  Irma M Puspitasari; Chiho Yamazaki; Rizky Abdulah; Mirasari Putri; Satomi Kameo; Takashi Nakano; Hiroshi Koyama
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

3.  The Peter Brojde lung cancer centre: a model of integrative practice.

Authors:  M Grossman; J Agulnik; G Batist
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

4.  Complementary and alternative medicine use among patients with thoracic malignancies.

Authors:  Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

5.  Survey on the worldwide Chronic Myeloid Leukemia Advocates Network regarding complementary and alternative medicine.

Authors:  Thomas Elsner; Ralph Muecke; Oliver Micke; Franz J Prott; Karsten Muenstedt; Anita Waldmann; Jan Geissler; Jutta Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-16       Impact factor: 4.553

6.  Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients.

Authors:  A C Conrad; K Muenstedt; O Micke; F J Prott; R Muecke; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-06       Impact factor: 4.553

Review 7.  Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Steve Doucette; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

Review 8.  Selenium and lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

9.  Emerging roles of mistletoes in malignancy management.

Authors:  Seema Patel; Suryakanta Panda
Journal:  3 Biotech       Date:  2013-03-07       Impact factor: 2.406

Review 10.  Updates on clinical studies of selenium supplementation in radiotherapy.

Authors:  Irma M Puspitasari; Rizky Abdulah; Chiho Yamazaki; Satomi Kameo; Takashi Nakano; Hiroshi Koyama
Journal:  Radiat Oncol       Date:  2014-05-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.